Nicholas Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Nicholas Investment Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-239,119	Closed	-$22.2M	–	227
2021 Q4	$22.2M	Buy	239,119 +39,709	+20%	+$2.62M	1.41%	11
2021 Q3	$11.9M	Sell	199,410 -98,837	-33%	-$5.84M	0.87%	43
2021 Q2	$20.3M	Sell	298,247 -29,695	-9%	-$1.94M	1.28%	24
2021 Q1	$22.8M	Buy	327,942 +51,309	+19%	+$3.95M	1.59%	9
2020 Q4	$21.3M	Buy	+276,633	New	+$20.7M	1.64%	14
2018 Q3	–	Sell	-109,811	Closed	-$4.79M	–	254
2018 Q2	$4.79M	Sell	109,811 -28,567	-21%	-$1.23M	0.34%	92
2018 Q1	$5.47M	Buy	+138,378	New	+$5.38M	0.39%	72

Nicholas Investment Partners's ARNA Position: Q1 2022 in Review

Nicholas Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 239,119 shares — an estimated $22.2M sold.

Nicholas Investment Partners first reported a position in ARNA in Q1 2018 and held it in 7 quarters. The position peaked at $22.8M in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Nicholas Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Nicholas Investment Partners sold 239,119 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22.2M.
Nicholas Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 7 quarters.
Nicholas Investment Partners's Arena Pharmaceuticals Inc position peaked at $22.8M in Q1 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Nicholas Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.